Blood glucose self-monitoring, which supports the achievement of individual blood glucose therapy goals and the avoidance of acute hypo- and hyperglycaemia, can be facilitated by continuous glucose monitoring with measurement of the ‘tissue glucose’ in the subcutaneous fatty tissue by a sensor and is mainly used by people on insulin therapy. Here, INS is linked to Hyperglycemia.